Send feedback

CLPB p.Val596Ala

c.1787T>C · VCV3669248

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely pathogenic
0.8821 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.5e-05%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
3
3-methylglutaconic aciduria, type VIIB

Computational evidence

Protein change
AlphaMissense0.8821likely pathogenic
REVEL0.454indeterminate
SaProtLLR -11.00damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI<0.2all four deltas below 0.2 · A>C here scores Δ0.66 · evaluated, not missing
Constraint at this position
ConservationphyloP 11GERP 1.8, phastCons 1
Regional constrainto/e 0.89unconstrained · MANE · 2,250 bp · p 0.067 · regional, not allelic
Overall
CADD26.7PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM V626A vs ClinVar V596A) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.5e-05% European (non-Finnish) · 1/1,176,188 alleles
Overall 0.000206% 3/1,457,064 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00321% 31,124
European (non-Finnish)grpmax 8.5e-05% 1,176,188

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CLPB
Protein
p.Val596Ala
Coding
c.1787T>C
MANE Select
NM_001258392
Type
single nucleotide variant
Location
chr11:72293614 (GRCh38)
Gene constraint
LOEUF 0.643 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 72.52 · 7 PDB
Full CLPB gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

3-methylglutaconic aciduria, type VIIB — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: neutropenia, severe congenital, 9, autosomal dominant3-methylglutaconic aciduria, type VIIA

For 3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome (Orphanet):

Inheritance
Autosomal recessive
Onset
Antenatal, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/clpb-p-val596ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown